Intestinal permeability and inflammation in patients on NSAIDs.
about
Gastrointestinal safety of AZD3582, a cyclooxygenase inhibiting nitric oxide donator: proof of concept study in humansSlipping through the Cracks: Linking Low Immune Function and Intestinal Bacterial Imbalance to the Etiology of Rheumatoid ArthritisGastrointestinal permeability during exercise: effects of aspirin and energy-containing beveragesIntestinal barrier function: molecular regulation and disease pathogenesisSelective inhibition of COX-2 in humans is associated with less gastrointestinal injury: a comparison of nimesulide and naproxenIleitis: when it is not Crohn's diseaseInflammatory bowel disease and spondylarthropathy.Effect of Lactobacillus ingestion on the gastrointestinal mucosal barrier alterations induced by indometacin in humans.Is non-steroidal anti-inflammaory drug (NSAID) enteropathy clinically more important than NSAID gastropathy?Monitoring complete blood counts and haemoglobin levels in osteoarthritis patients: results from a European survey investigating primary care physician behaviours and understanding.Determining small bowel integrity following drug treatment.Immunology of inflammatory bowel disease and molecular targets for biologics.COX-2 inhibition with rofecoxib does not increase intestinal permeability in healthy subjects: a double blind crossover study comparing rofecoxib with placebo and indomethacin.Rebamipide suppresses diclofenac-induced intestinal permeability via mitochondrial protection in mice.The G.U.T. of gut.Rheumatoid arthritis: acute presentations and urgent complications.Mucosal healing effect of mesalazine granules in naproxen-induced small bowel enteropathyPG-mediated closure of paracellular pathway and not restitution is the primary determinant of barrier recovery in acutely injured porcine ileumNSAID-Induced Enteropathy in Rheumatoid Arthritis Patients with Chronic Occult Gastrointestinal Bleeding: A Prospective Capsule Endoscopy Study.Non-invasive investigation in patients with inflammatory joint disease.Modified Mediterranean Diet for Enrichment of Short Chain Fatty Acids: Potential Adjunctive Therapeutic to Target Immune and Metabolic Dysfunction in Schizophrenia?Small bowel injury in low-dose aspirin users.Role of non-steroidal anti-inflammatory drugs on intestinal permeability and nonalcoholic fatty liver disease.A protective effect of melatonin on intestinal permeability is induced by diclofenac via regulation of mitochondrial function in mice.Kinetic analysis of 5 sugar probes in dog serum after orogastric administration.Prostaglandins and the induction of food sensitive enteropathy.COX-1 and COX-2 products in the gut: therapeutic impact of COX-2 inhibitors.Randomized, double-blind, pilot study of geranylgeranylacetone versus placebo in patients taking low-dose enteric-coated aspirin. Low-dose aspirin-induced small bowel damage.The effect of probiotics on gastric mucosal permeability in humans administered with aspirin.In vivo influence of nicotine on human basal and NSAID-induced gut barrier function.Nonsteroidal Anti-Inflammatory Drug-Induced Leaky Gut Modeled Using Polarized Monolayers of Primary Human Intestinal Epithelial Cells.Naproxen-induced anemia and hypoalbuminemia in a 16-month-old child.Prevalence of non-steroidal anti-inflammatory drug-induced enteropathy determined by double-balloon endoscopy: a Japanese multicenter study.Pretreatment with indomethacin results in increased heat stroke severity during recovery in a rodent model of heat stroke.Duodenal intraepithelial lymphocytosis with normal villous architecture: common occurrence in H. pylori gastritis.Different effects of anti-TNF-alpha biologic drugs on the small bowel macroscopic inflammation in patients with ankylosing spondylitis.Endoscopic and Pathologic Resolution of Chronic Nonsteroidal Anti-Inflammatory Drug-Induced Diaphragm-Like Colonic Strictures and Ulceration.
P2860
Q24669542-18A3391F-C38E-41E7-B40B-DB4BA03F92D6Q27008648-C900904F-3F90-4C74-9822-93ADDB19AC67Q28183786-F78F394D-9AC7-4B08-89B7-5E83F3B52F65Q28250081-C5F85B7F-096C-4F5A-930B-70A2D071A7B6Q28348645-8BEC1585-E5F6-486F-965F-8A0B95C2CEC8Q34037331-A366AE5B-398C-4390-A710-6E871D6372C2Q34474693-B1EAA356-2981-4855-8C48-0B96153BF913Q34512635-87773619-2529-4E03-B0EA-CB89686DABA5Q34565398-09985101-7A1B-40F7-8BB5-BF97EE422154Q34949982-D1DB92F2-EE82-4FA6-A4CF-E339604ACA49Q35200057-8AE98CC0-0BA6-4346-9DD8-563276ADE45CQ35222593-F5DCD14C-2373-4969-A4E4-215E0F4F10BEQ35361527-AE5A78D5-AC4E-4455-9733-0B9B2F9FAC30Q35813196-33FDB1DA-58DD-46E2-973C-84B61224D6E8Q35932416-A8D34D83-2285-40A8-BBD7-37475BC2F4A5Q36490328-BE90DFE9-0FAF-4897-BCD0-F4BE6558E949Q36616822-C40A955A-2EE5-42D3-9BDF-41E679AE9E8DQ36744555-4A080B7D-5A15-451D-8A2F-9EF618AD358EQ37409122-BCCF8C45-FE37-4609-8E3B-093223E032F5Q37495751-AD8D7278-B2CF-44F1-8FB9-B8E1301CDE0AQ37721268-012E6161-C1C7-4CDB-B4A0-7B75D12D9A3DQ38287025-4C515AB4-499C-4907-9EDB-8389EB2266B5Q38707937-B46BE1FA-B484-4A22-955D-A041A7B1FDA6Q39004449-2AA102B9-D036-4CA0-9C7A-A6B1684D2E4CQ41770258-3F6052AA-3BD2-4C23-B569-CE639D3860C6Q42956609-6A8438EC-F0D8-4EDC-8D0B-27D13E5E12B2Q43086302-987CE7D7-F8AC-4F23-97EE-16DB7D9CC8CDQ43227958-9E8FE233-B6D2-48AA-A807-C03437E1CC96Q44231028-D517B1F5-B42A-4136-99CE-47DFB641797FQ44435838-712EA833-2C55-49D7-A31C-AC9ACB48B0D5Q44876695-DF8A6B2F-A223-4E96-8787-ED8F5E53CC35Q46480231-4A23D292-0B46-4E27-B66D-9590896DA8B2Q46682965-FD2C018F-7A4A-4DEC-BCC0-8954E6960A6FQ50205410-D426ABA0-FB30-498C-B78E-EBE4651F2534Q50773232-262D0785-914E-4344-94A4-101950C5568CQ51037569-D3A1B27B-80BA-49F9-868E-82AD34D6A23AQ55395877-6E8DC123-B4BF-47A3-859A-65C849AA988E
P2860
Intestinal permeability and inflammation in patients on NSAIDs.
description
1998 nî lūn-bûn
@nan
1998 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Intestinal permeability and inflammation in patients on NSAIDs.
@ast
Intestinal permeability and inflammation in patients on NSAIDs.
@en
type
label
Intestinal permeability and inflammation in patients on NSAIDs.
@ast
Intestinal permeability and inflammation in patients on NSAIDs.
@en
prefLabel
Intestinal permeability and inflammation in patients on NSAIDs.
@ast
Intestinal permeability and inflammation in patients on NSAIDs.
@en
P2093
P2860
P356
P1433
P1476
Intestinal permeability and inflammation in patients on NSAIDs.
@en
P2093
Bjarnason I
Macpherson A
Sigthorsson G
P2860
P304
P356
10.1136/GUT.43.4.506
P407
P577
1998-10-01T00:00:00Z